STOCK EXCHANGE: Kemira’s share is down after a recommendation downgrade in a sluggish stock market – Nanoform plunges

The Helsinki Stock Exchange opened looking for direction. The slight rise of the first minutes had time to melt as the trading progressed. At 10:22 a.m., the general index OMX Helsinki was down 0.05 percent at 12465.49 points. However, there were more rising stocks on the main list than falling stocks.

In the morning, Asian markets were mainly down, and earlier on Monday evening in New York, the S&P 500 index had ended up with a 0.4 percent decrease. In the morning, the New York Index Futures have predicted a 0.7-0.8 percent increase for the afternoon opening in New York.

Investors are following mixed news about the Iran crisis.

At the top of the exchange, Nordea’s share price was up 0.7 percent at 14.64 euros. The price of the second-place Nokia was down 1.4 percent.

Nordea raised Liquid the target price of the share to 30 euros from 24 euros. The recommendation is still buy. Neste’s share price was down 0.5 percent at EUR 27.52 in the third quarter. About the exchange tip’s shares Kemira the share price was in the deepest decline of 3.8 percent at 18.93 euros. Kepler Cheuvreux lowered Kemira’s recommendation to reduce, while the previous one was hold.

Pharmaceutical technology company Nanoform said late Monday that it is delaying the marketing authorization application for nanoenzalutamide in Europe due to regulatory feedback. The permit application was originally supposed to be submitted in May. In the morning, the share price was down 32.9 percent at EUR 0.408.

To organize a share issue Bioretecin the share price fluctuated in a big fork on Monday after the issue’s subscription rights were released. Most of the price of the share was committed to the subscription right, by calculation up to about 90 percent. Trading with subscription rights is possible on the stock exchange from April 7 to April 15, 2026. The subscription period for new shares is April 7-April 21, 2026.

The reason for the big fluctuation is partly the fact that trading is currently only possible with old Bioretec stub shares, which account for only a fraction of the company’s post-IPO market value. The stock price ended at EUR 0.072 on Monday, which was almost six times higher than the neutral price after the withdrawal of subscription rights.

On the other hand, the share price had fallen very strongly before the issue, and Monday’s closing price, corrected by the withdrawal of the subscription right, corresponded to the share’s November level. The company announced the anti-planning for the first time in February.

On Tuesday morning, after just over 20 minutes of trading, the price of Bioretec’s old share was down three percent at 0.0698 euros. However, the price had time to fluctuate as high as EUR 0.09, so the fluctuation seems to continue today, Tuesday.

Bank of Åland a dividend of EUR 2.75 will be released from the share today, Tuesday. In the morning, the share price was down 3.9 percent and 2.00 euros at 49.40 euros.

Kreate continues to lift

Inderes raised Creatine the target price of the share to 16.00 euros from 15.00 euros. The recommendation is still more. Kreate issued a positive earnings warning on Monday and the share price rose 8.4 percent on Monday. On Tuesday morning, Kreate’s share price was up 0.7 percent at 14.30 euros.

Inderes counted Marimekkon the share’s target price to 11.50 euros from 12.50 euros. The investment recommendation is still more. Marimekko’s share price was up 0.4 percent at 10.22 euros.

JP Morgan chicks Metson the target price of the share to 17.50 euros from 18.00 euros. The recommendation is still more. Metso’s share price was up 0.9 percent at 14.575 euros.

Nordea fell Elisa’s to the stock’s recommendation level sell, previous hold. The target price is 38 euros. Elisa’s share price was down 0.1 percent at 42.22 euros.

Inderes counted Housing portfolio decrease to the level of investment recommendation, previous increase. The target price of the share fell to 81 euros from 92 euros. In the morning, Asuntosalku shares have not yet been traded.

Addition: Nanoform’s news and price reaction added to the article at 10:51